Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Colorcon
Express Scripts
Dow
Moodys

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Stanlabs Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for STANLABS PHARM, and what generic and branded alternatives to STANLABS PHARM drugs are available?

STANLABS PHARM has one approved drug.



Summary for Stanlabs Pharm
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Stanlabs Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stanlabs Pharm MEPROBAMATE meprobamate TABLET;ORAL 014474-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Stanlabs Pharm MEPROBAMATE meprobamate TABLET;ORAL 014474-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
AstraZeneca
Johnson and Johnson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.